Related Experiment Videos

The effect of continuous heparin infusion for one year on serum cholesterol and triglyceride concentrations in the

Atherosclerosis
|January 1, 1977
PubMed

Insights

Long-term intravenous heparin therapy in dogs significantly elevated serum cholesterol levels. This finding suggests potential implications for using heparin in treating human atherosclerosis.

Area of Science:

  • Veterinary Medicine
  • Pharmacology
  • Biochemistry

Background:

  • Long-term anticoagulation is crucial for managing atherosclerotic conditions.
  • Heparin is a widely used anticoagulant, but its long-term effects on lipid metabolism require further investigation.

Purpose of the Study:

  • To evaluate the long-term effects of continuous intravenous heparin administration on serum lipid profiles in normal dogs.

Main Methods:

  • Fourteen normal dogs received continuous intravenous heparin infusions (666 units/kg/day) for one year via implantable pumps.
  • Eight control dogs received bacteriostatic water infusions under identical conditions.
  • Serum cholesterol and triglyceride levels were monitored throughout the study.

Main Results:

  • Serum cholesterol concentrations in the heparin group increased by 50% above control values after one month and remained significantly elevated (P < 0.05) for 11 months.
  • Serum triglyceride levels showed no significant changes between the heparin and control groups.
  • Heparin's known activation of lipoprotein lipase may explain the observed increase in free fatty acids, potentially contributing to cholesterol elevation.

Conclusions:

  • Continuous one-year intravenous heparin infusion in dogs leads to a significant and sustained increase in serum cholesterol.
  • These findings suggest a potential link between long-term heparin use and altered lipid metabolism, with implications for managing atherosclerosis in humans.

Related Concept Videos